Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-68.88	-282.76	-167.43
Graham Fair Price	35.71	65.52	48.28
PEG	-61.53	-0.03	0.09
Price/Book	22.41	0.58	0.48
Price/Cash Flow	36.36	-9.71	-15.25
Prices/Earnings	-32.85	8.95	-13.33
Price/Sales	9.93	5.72	5.21
Price/FCF	36.36	-9.71	-15.25
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-11.48	0.89	1.00
Operating Margin	99.50	0.23	-0.11
ROA	81.75	< 0.005	< 0.005
ROE	< 0.005	0.02	82.30
ROIC	< 0.005	< 0.005	97.03
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.02	27.48
Dividends QOQ	-0.02	-0.02	19.91
EBIT QOQ	-1.45	3.23	123.08
EPS QOQ	-1.52	2.66	74.55
FCF QOQ	-1.46	-0.93	35.85
Revenue QOQ	-0.06	0.12	85.08
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	258.87	262.77	1.51
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.61	0.61	-1.02
Quick Ratio	5.66	8.04	42.03
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	107.58	108.14	0.51
Cash	271.18	275.22	1.49
Capex	-0.92	-0.84	8.99
Free Cash Flow	-3.37	-6.51	-93.34
Revenue	9.87	11.04	11.92
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.66	0.34	-93.91
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-65.57	-76.37	-16.47
Naive Interpretation	Member

06 - Financial Health · Bad

Rating